Remus Pharmaceuticals IPO description – Incorporated in 2015, Remus Pharmaceuticals is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. It also deals in API (Active Pharmaceutical Ingredient). The company also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries.
The company has cultivated strong and dependable customer relationships ranging from generic distributors, regional distributors, and multinational distributors to Hospitals and Clinics through a responsive distribution network. Remus’ clients are spread in more than 20 countries and its product portfolio consisted of 429 products, as on 31 January 2023.
Remus Pharmaceuticals deals in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.
Promoters of Remus Pharmaceuticals – Mr. Arpit Deepakkumar Shah, Ms. Roma Vinodbhai Shah, Mr. Swapnil Jatinbhai Shah and Mrs. Anar Swapnil Shah
Remus Pharmaceuticals IPO Details
| Remus Pharmaceuticals IPO Dates | 17 – 19 May 2023 |
| Remus Pharmaceuticals IPO Price | INR 1,150 – 1,229 per share |
| Fresh issue | 3,88,000 shares (INR 44.62 – 47.69 crores) |
| Offer For Sale | Nil |
| Total IPO size | 3,88,000 shares (INR 44.62 – 47.69 crores) |
| Minimum bid (lot size) | 100 shares (INR 122,900) |
| Face Value | INR 10 per share |
| Retail Allocation | 35% |
| Listing On | NSE SME |
Remus Pharmaceuticals Financial Performance
| Â | FY 2020 | FY 2021 | FY 2022 | 9M FY 2023 |
| Revenue | 11.92 | 18.42 | 24.72 | 32.39 |
| Expenses | 11.67 | 17.87 | 20.89 | 24.92 |
| Net income | 0.81 | 1.03 | 3.39 | 6.44 |
Remus Pharmaceuticals Offer News
- Remus Pharmaceuticals RHP
- Remus Pharmaceuticals Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Remus Pharmaceuticals Valuations & Margins
| FY 2020 | FY 2021 | FY 2022 | |
| EPS | 8.12 | 10.26 | 33.86 |
| PE ratio | – | – | 33.96 – 36.30 |
| RONW (%) | 40.17 | 33.68 | 52.64 |
| NAV | – | – | 64.32 |
| ROCE (%) | 47.76 | 41.90 | 69.99 |
| EBITDA (%) | 10.42 | 8.51 | 19.38 |
| Debt/Equity | 0.18 | 0.09 | 0.03 |
Remus Pharmaceuticals IPO GMP Today
| Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
| 26 May 2023 | 82 | – | 30,000 |
| 25 May 2023 | 80 | – | 27,000 |
| 24 May 2023 | 80 | – | 27,000 |
| 23 May 2023 | 80 | – | 25,000 |
| 22 May 2023 | 90 | – | 15,000 |
| 20 May 2023 | 95 | – | 12,000 |
| 19 May 2023 | 110 | – | 15,000 |
| 18 May 2023 | 120 | – | 15,000 |
| 17 May 2023 | 125 | – | 15,000 |
| 16 May 2023 | 120 | – | 12,000 |
| 15 May 2023 | 130 | – | 15,000 |
| 12 May 2023 | 135 | – | – |
| 11 May 2023 | 150 | – | – |
Remus Pharmaceuticals IPO Subscription – Live Updates
| Category | QIB | Non retail | Retail | Total |
| Shares Offered | 73,700 | 74,800 | 129,000 | 277,500 |
| 19 May 2023 | 20.24 | 127.59 | 36.19 | 56.59 |
| 18 May 2023 | 2.61 | 2.95 | 7.42 | 4.94 |
| 17 May 2023 | 0.00 | 0.17 | 0.78 | 0.41 |
Remus Pharmaceuticals Offer Lead Manager
BEELINE CAPITAL ADVISORS PRIVATE LIMITED
807, Phoenix, Opp. Girish Cold Drinks,
Near Vijay Cross Roads, Navrangpura, Ahmedabad -380009
Phone: 079 4840 5357
Email: [email protected]
Website:Â www.beelinemb.com
Remus Pharmaceuticals Offer Registrar
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park,
Lal Bahadur Shastri Marg, Vikhroli (West),
Mumbai, Maharashtra, India – 400 083
Phone: +91 810 811 4949
Email: [email protected]
Website:Â www.linkintime.co.in
Remus Pharmaceuticals Contact Details
REMUS PHARMACEUTICALS LIMITED
1101 to 1103, South Tower, One 42,
B/H Ashok Vatika, Nr. Jayantilal Park BRTS,
Ambli Bopal Road, Ahmedabad – 380054, Gujarat
Phone: +079- 2999 9857
E-mail: [email protected]
Website: www.remuspharma.com
Remus Pharmaceuticals IPO Allotment Status
Remus Pharmaceuticals IPO allotment status is now available on Link Intime’s website. Click on Link Intime IPO weblink to get allotment status.
Remus Pharmaceuticals IPO Dates & Listing Performance
| IPO Opening Date | 17 May 2023 |
| IPO Closing Date | 19 May 2023 |
| Finalization of Basis of Allotment | 24 May 2023 |
| Initiation of refunds | 25 May 2023 |
| Transfer of shares to demat accounts | 26 May 2023 |
| Remus Pharmaceuticals IPO Listing Date | 29 May 2023 |
| Opening Price on NSE SME | INR 1,711.25 per share (up 39.24%) |
| Closing Price on NSE SME | INR 1,796.80 per share (up 46.20%) |
Read Also: Nifty Pharma Stocks List With Weightage in 2023
Remus Pharmaceuticals IPO FAQs
What is the Remus Pharmaceuticals offer size?
Remus Pharmaceuticals offer size is INR 44.62 – 47.69 crores.
What is the Remus Pharmaceuticals IPO Price Band?
Remus Pharmaceuticals public offer price is INR 1,150 – 1,229 per share.
What is the lot size of the Remus Pharmaceuticals IPO?
Remus Pharmaceuticals offer a lot size is 100 shares.
What is Remus Pharmaceuticals IPO GMP today?
Remus Pharmaceuticals IPO GMP today is INR 82 per share.
What is the Remus Pharmaceuticals kostak rate today?
Remus Pharmaceuticals kostak rate today is NA per application.
What is Remus Pharmaceuticals Subject to Sauda rate today?
Remus Pharmaceuticals Subject to Sauda rate today is INR 30,000 per application.
